BlackRock’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$954K Buy
146,273
+174
+0.1% +$1.08K ﹤0.01% 4363
2025
Q4
$836K Buy
146,099
+273
+0.2% +$1.68K ﹤0.01% 4355
2025
Q3
$995K Buy
145,826
+478
+0.3% +$3.62K ﹤0.01% 4284
2025
Q2
$1.31M Sell
145,348
-493,471
-77% -$2.93M ﹤0.01% 4171
2025
Q1
$3.44M Sell
638,819
-16,817
-3% -$114K ﹤0.01% 3790
2024
Q4
$4.88M Buy
655,636
+8,145
+1% +$67K ﹤0.01% 3743
2024
Q3
$5.85M Buy
647,491
+37,455
+6% +$386K ﹤0.01% 3639
2024
Q2
$6.48M Buy
610,036
+461,760
+311% +$4.92M ﹤0.01% 3588
2024
Q1
$1.31M Buy
148,276
+642
+0.4% +$5.22K ﹤0.01% 4119
2023
Q4
$1.01M Buy
147,634
+5,405
+4% +$44.4K ﹤0.01% 4252
2023
Q3
$1.39M Sell
142,229
-3,001
-2% -$24K ﹤0.01% 4128
2023
Q2
$703K Buy
145,230
+2,873
+2% +$12.5K ﹤0.01% 4387
2023
Q1
$572K Sell
142,357
-8,720
-6% -$35K ﹤0.01% 4498
2022
Q4
$583K Buy
151,077
+112
+0.1% +$517 ﹤0.01% 4571
2022
Q3
$726K Sell
150,965
-1,603
-1% -$7.58K ﹤0.01% 4598
2022
Q2
$694K Buy
152,568
+449
+0.3% +$2.21K ﹤0.01% 4666
2022
Q1
$817K Sell
152,119
-1,226
-0.8% -$6.56K ﹤0.01% 4729
2021
Q4
$926K Buy
153,345
+9,303
+6% +$57.1K ﹤0.01% 4693
2021
Q3
$1.03M Sell
144,042
-3,578
-2% -$28.8K ﹤0.01% 4544
2021
Q2
$1.24M Sell
147,620
-399,398
-73% -$3.44M ﹤0.01% 4447
2021
Q1
$4.53M Buy
547,018
+7,335
+1% +$52K ﹤0.01% 3984
2020
Q4
$3.49M Buy
539,683
+72,360
+15% +$457K ﹤0.01% 3844
2020
Q3
$2.76M Buy
467,323
+5,717
+1% +$37.6K ﹤0.01% 3806
2020
Q2
$3.24M Buy
461,606
+294,092
+176% +$2.15M ﹤0.01% 3686
2020
Q1
$872K Sell
167,514
-289
-0.2% -$1.98K ﹤0.01% 3914
2019
Q4
$1.24M Buy
167,803
+738
+0.4% +$6.12K ﹤0.01% 3937
2019
Q3
$1.45M Sell
167,065
-1,072
-0.6% -$9.17K ﹤0.01% 3853
2019
Q2
$1.34M Buy
168,137
+136,995
+440% +$1.25M ﹤0.01% 3918
2019
Q1
$320K Sell
31,142
-3,471
-10% -$31.1K ﹤0.01% 4170
2018
Q4
$234K Buy
34,613
+234
+0.7% +$1.7K ﹤0.01% 4198
2018
Q3
$280K Buy
34,379
+1,354
+4% +$12.7K ﹤0.01% 4254
2018
Q2
$317K Buy
33,025
+2,857
+9% +$27.4K ﹤0.01% 4213
2018
Q1
$302K Sell
30,168
-88,003
-74% -$681K ﹤0.01% 4131
2017
Q4
$774K Buy
118,171
+1,444
+1% +$9.68K ﹤0.01% 3967
2017
Q3
$789K Sell
116,727
-1,262
-1% -$8.6K ﹤0.01% 3974
2017
Q2
$850K Buy
117,989
+5,559
+5% +$34K ﹤0.01% 3884
2017
Q1
$613K Buy
+112,430
New +$612K ﹤0.01% 3914
2013
Q3
Sell
-3,543
Closed -$13K 3112
2013
Q2
$13K Buy
+3,543
New +$13.8K ﹤0.01% 2514

Other funds holding ULBI

BlackRock's ULBI Position: Q1 2026 in Review

BlackRock increased its Ultralife (ULBI) stake by 0.12% in Q1 2026, buying an estimated $1.08K and bringing the position to 146,273 shares worth $954K. The position accounts for ﹤0.01% of the portfolio, ranked #4363.

BlackRock first reported a position in ULBI in Q2 2013 and has held it in 38 quarters since. The position peaked at $6.48M in Q2 2024. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • BlackRock held 146,273 shares of Ultralife worth $954K as of Q1 2026.
  • BlackRock bought 174 Ultralife shares in Q1 2026, an estimated $1.08K.
  • Ultralife made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4363 holding.
  • BlackRock first reported a position in Ultralife in Q2 2013 and has held it in 38 quarters since.
  • BlackRock's Ultralife position peaked at $6.48M in Q2 2024.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.